Hobart Private Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-11,012
| Closed | -$652K | – | 52 |
|
|
2021
Q3 | $652K | Sell |
11,012
-530
| -5% | -$31.4K | 0.26% | 54 |
|
|
2021
Q2 | $771K | Sell |
11,542
-2,236
| -16% | -$149K | 0.32% | 40 |
|
|
2021
Q1 | $870K | Sell |
13,778
-1,480
| -10% | -$93.4K | 0.36% | 32 |
|
|
2020
Q4 | $946K | Sell |
15,258
-369
| -2% | -$22.9K | 0.41% | 30 |
|
|
2020
Q3 | $942K | Buy |
15,627
+13
| +0.1% | +$784 | 0.49% | 32 |
|
|
2020
Q2 | $918K | Buy |
15,614
+5,060
| +48% | +$298K | 0.52% | 45 |
|
|
2020
Q1 | $588K | Buy |
10,554
+899
| +9% | +$50.1K | 0.4% | 62 |
|
|
2019
Q4 | $620K | Buy |
9,655
+969
| +11% | +$62.2K | 0.38% | 62 |
|
|
2019
Q3 | $440K | Buy |
8,686
+387
| +5% | +$19.6K | 0.3% | 76 |
|
|
2019
Q2 | $376K | Buy |
8,299
+905
| +12% | +$41K | 0.26% | 85 |
|
|
2019
Q1 | $353K | Sell |
7,394
-3,173
| -30% | -$151K | 0.27% | 98 |
|
|
2018
Q4 | $549K | Buy |
10,567
+4,206
| +66% | +$219K | 0.47% | 62 |
|
|
2018
Q3 | $395K | Buy |
+6,361
| New | +$395K | 0.3% | 89 |
|